Maria Horga
Chief Tech/Sci/R&D Officer bei ATEA PHARMACEUTICALS, INC.
Vermögen: 103 683 $ am 31.03.2024
Profil
Maria Arantxa Horga bekleidet derzeit die Position des Chief Medical Officer bei Atea Pharmaceuticals, Inc. In ihrer bisherigen Laufbahn war sie Group Director-Global Clinical Research bei Bristol Myers Squibb Co., Vice President & Global Head-Clinical Program bei Roche Innovation Center, Vice President-Pharmacovigilance bei Biohaven Pharmaceuticals, Inc. und Head-Translational Medicine bei F. Hoffmann-La Roche Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.02.2024 | 25 664 ( 0,03% ) | 103 683 $ | 31.03.2024 |
Aktive Positionen von Maria Horga
| Unternehmen | Position | Beginn |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01.10.2020 |
Ehemalige bekannte Positionen von Maria Horga
| Unternehmen | Position | Ende |
|---|---|---|
Biohaven Pharmaceuticals, Inc.
 Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 01.08.2020 |
| Roche Innovation Center | Corporate Officer/Principal | 01.08.2019 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01.01.2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Maria Horga
| University of Santander | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ATEA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Commercial Services |
| Roche Innovation Center |
